Cargando…
Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease
The beneficial effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in hypertensive patients with peripheral arterial disease (PAD) depends on long-term persistence. The aims of our study were to analyse gender differences in non-persistence with ACEIs...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313155/ https://www.ncbi.nlm.nih.gov/pubmed/35884784 http://dx.doi.org/10.3390/biomedicines10071479 |
_version_ | 1784754009972670464 |
---|---|
author | Wawruch, Martin Murin, Jan Tesar, Tomas Paduchova, Martina Petrova, Miriam Celovska, Denisa Havelkova, Beata Trnka, Michal Masarykova, Lucia Alfian, Sofa D. Aarnio, Emma |
author_facet | Wawruch, Martin Murin, Jan Tesar, Tomas Paduchova, Martina Petrova, Miriam Celovska, Denisa Havelkova, Beata Trnka, Michal Masarykova, Lucia Alfian, Sofa D. Aarnio, Emma |
author_sort | Wawruch, Martin |
collection | PubMed |
description | The beneficial effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in hypertensive patients with peripheral arterial disease (PAD) depends on long-term persistence. The aims of our study were to analyse gender differences in non-persistence with ACEIs/ARBs, and to identify the characteristics associated with the likelihood of non-persistence. Our study cohort included 7080 hypertensive patients (4005 women and 3075 men) aged ≥65 years, treated with ACEIs/ARBs, in whom PAD was diagnosed between 1 January and 31 December 2012. Non-persistence was identified according to a treatment gap of 6 months without ACEI/ARB prescriptions. The characteristics associated with non-persistence were identified using the Cox regression model. At the end of the 5-year follow-up, 23.2% of the whole study cohort, 22.3% of men, and 23.9% of women were non-persistent with ACEIs/ARBs, with no significant gender differences in persistence. While a number of characteristics were associated with non-persistence, only three characteristics had consistent, statistically significant associations in both genders: being a new ACEI/ARB user increased the likelihood of non-persistence, and general practitioner as index prescriber and increasing the overall number of medications decreased the likelihood of non-persistence. Information on the differences in characteristics that are associated with non-persistence between genders may help to better identify patients for whom special attention should be paid to improve their persistence. |
format | Online Article Text |
id | pubmed-9313155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93131552022-07-26 Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease Wawruch, Martin Murin, Jan Tesar, Tomas Paduchova, Martina Petrova, Miriam Celovska, Denisa Havelkova, Beata Trnka, Michal Masarykova, Lucia Alfian, Sofa D. Aarnio, Emma Biomedicines Article The beneficial effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in hypertensive patients with peripheral arterial disease (PAD) depends on long-term persistence. The aims of our study were to analyse gender differences in non-persistence with ACEIs/ARBs, and to identify the characteristics associated with the likelihood of non-persistence. Our study cohort included 7080 hypertensive patients (4005 women and 3075 men) aged ≥65 years, treated with ACEIs/ARBs, in whom PAD was diagnosed between 1 January and 31 December 2012. Non-persistence was identified according to a treatment gap of 6 months without ACEI/ARB prescriptions. The characteristics associated with non-persistence were identified using the Cox regression model. At the end of the 5-year follow-up, 23.2% of the whole study cohort, 22.3% of men, and 23.9% of women were non-persistent with ACEIs/ARBs, with no significant gender differences in persistence. While a number of characteristics were associated with non-persistence, only three characteristics had consistent, statistically significant associations in both genders: being a new ACEI/ARB user increased the likelihood of non-persistence, and general practitioner as index prescriber and increasing the overall number of medications decreased the likelihood of non-persistence. Information on the differences in characteristics that are associated with non-persistence between genders may help to better identify patients for whom special attention should be paid to improve their persistence. MDPI 2022-06-22 /pmc/articles/PMC9313155/ /pubmed/35884784 http://dx.doi.org/10.3390/biomedicines10071479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wawruch, Martin Murin, Jan Tesar, Tomas Paduchova, Martina Petrova, Miriam Celovska, Denisa Havelkova, Beata Trnka, Michal Masarykova, Lucia Alfian, Sofa D. Aarnio, Emma Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title | Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title_full | Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title_fullStr | Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title_full_unstemmed | Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title_short | Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease |
title_sort | gender differences in non-persistence with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among older hypertensive patients with peripheral arterial disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313155/ https://www.ncbi.nlm.nih.gov/pubmed/35884784 http://dx.doi.org/10.3390/biomedicines10071479 |
work_keys_str_mv | AT wawruchmartin genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT murinjan genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT tesartomas genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT paduchovamartina genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT petrovamiriam genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT celovskadenisa genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT havelkovabeata genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT trnkamichal genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT masarykovalucia genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT alfiansofad genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease AT aarnioemma genderdifferencesinnonpersistencewithangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersamongolderhypertensivepatientswithperipheralarterialdisease |